Malek Faham
InvestorChief Scientist at Illumina Ventures · Board director at Protillion Biosciences
About
A physician-scientist and entrepreneur who co-founded Sequenta (acquired by Adaptive Biotechnologies in 2015) and ParAllele Biosciences (acquired by Affymetrix in 2005), later serving as VP of Research and Oncology Technology at Affymetrix. He holds a Ph.D. in Human Genetics and an MD from UCSF, with 60 peer-reviewed publications and 40 US patents.
Board director at Protillion Biosciences
Intro paths
→
In turn, Malek can intro founders to Protillion Biosciences's investors below.
Protillion Biosciences's investors · 2
Co-founders at Protillion Biosciences
.png)
Colleagues at Illumina Ventures
Abhijit 'Ron' Mazumder, Ph.D.
Partner at Illumina Ventures
Abhijit "Ron" Mazumder
Partner at Illumina Ventures
Alexis Yongmei Ji
Partner at Illumina Ventures
Bill Rastetter
Advisor at Illumina Ventures
Bill Rastetter, Ph.D.
Advisor at Illumina Ventures
Charles Lin
Principal at Illumina Ventures
Charles White
Senior Associate at Illumina Ventures
Charles White, Ph.D.
Principal at Illumina Ventures
Frequently asked questions
- Who is Malek Faham?
- A physician-scientist and entrepreneur who co-founded Sequenta (acquired by Adaptive Biotechnologies in 2015) and ParAllele Biosciences (acquired by Affymetrix in 2005), later serving as VP of Research and Oncology Technology at Affymetrix. He holds a Ph.D. in Human Genetics and an MD from UCSF, with 60 peer-reviewed publications and 40 US patents.
- Where does Malek Faham work?
- Malek Faham is Chief Scientist at Illumina Ventures and Board director at Protillion Biosciences.